Format

Send to

Choose Destination
Oncol Res Treat. 2017;40(3):120-127. doi: 10.1159/000458443. Epub 2017 Feb 24.

Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients.

Abstract

The number of patients with HIV (human immunodeficiency virus) requiring treatment for malignancy is increasing worldwide. Concurrent treatment of HIV and malignancy is complicated by unpredictable drug-drug interactions, which can cause potentially life-threatening toxicities and ineffective treatment of either disease. This article aims to provide a practical approach to drug interactions and their management in this context to help deliver effective and safe treatment of both the malignancy and HIV.

PMID:
28253501
DOI:
10.1159/000458443
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center